Repositioning Candidate Details
| Candidate ID: | R1282 |
| Source ID: | DB09284 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Imolamine |
| Synonyms: | 3-Phenyl-4-diethylaminoethyl-5-imino-1,2,4-oxadiazol; Imolamine |
| Molecular Formula: | C14H20N4O |
| SMILES: | CCN(CC)CCN1C(=N)ON=C1C1=CC=CC=C1 |
| Structure: |
|
| DrugBank Description: | Imolamine is a compound with a molecular weight of 260.33 g/mol with the formula diethylamine. It is developed under the brand name Coremax by Novartis consumer health SA. |
| CAS Number: | 318-23-0 |
| Molecular Weight: | 260.341 |
| DrugBank Indication: | Imolamine is indicated for the treatment of angina pectoris. The hydrochloride form is used as a local anesthetic. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I08 | 114 | Cardiovascular system disease | A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis. http://en.wikipedia.org/wiki/Circulatory_system | disease of anatomical entity | Details |